From Name:
From Email:
To Name:
To Email:

Optional Message:

Andexanet alfa reverses blood thinning of rivaroxaban

from APhA

Full results from a Phase III study examining Portola Pharmaceutical's developmental compound andexanet alfa found it rapidly and significantly reversed the anticoagulant effects of rivaroxaban. These results will be presented at the American College of Cardiology meeting March 16. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063